BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Prognosis
41 results:

  • 1. Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer.
    Kotwal A; Gustafson MP; Bornschlegl S; Dietz AB; Delivanis D; Ryder M
    Front Immunol; 2023; 14():1325343. PubMed ID: 38235146
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling.
    Wang L; Wang D; Zeng X; Zhang Q; Wu H; Liu J; Wang Y; Liu G; Pan Y
    Int J Biol Sci; 2023; 19(7):2256-2269. PubMed ID: 37151882
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma.
    Wen Z; Liu H; Qiao D; Chen H; Li L; Yang Z; Zhu C; Zeng Z; Chen Y; Liu L
    ACS Nano; 2023 Apr; 17(8):7194-7206. PubMed ID: 37057967
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma.
    Wang L; Wang D; Yang L; Zeng X; Zhang Q; Liu G; Pan Y
    Front Immunol; 2022; 13():989286. PubMed ID: 36618352
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
    Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients.
    Yin G; Guo W; Liu H; Huang Z; Chen X
    Curr Probl Cancer; 2022 Aug; 46(4):100878. PubMed ID: 35752137
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.
    Li R; Huang X; Yang W; Wang J; Liang Y; Zhang T; Mao Q; Xia W; Xu L; Xu X; Dong G; Jiang F
    J Pathol Clin Res; 2022 Sep; 8(5):422-435. PubMed ID: 35711130
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Protein C receptor maintains cancer stem cell properties via activating lipid synthesis in nasopharyngeal carcinoma.
    Zhang P; He Q; Wang Y; Zhou G; Chen Y; Tang L; Zhang Y; Hong X; Mao Y; He Q; Yang X; Liu N; Ma J
    Signal Transduct Target Ther; 2022 Feb; 7(1):46. PubMed ID: 35169126
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
    Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
    Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A low proportion of regulatory T cells before chemoradiotherapy predicts better overall survival in esophageal cancer.
    Lan F; Xu B; Li J
    Ann Palliat Med; 2021 Feb; 10(2):2195-2202. PubMed ID: 33725774
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-183/TMSB4Y, a new potential signaling axis, involving in the progression of laryngeal cancer via modulating cell adhesion.
    Lu B; Yu Y; Xing XL; Liu RY
    J Recept Signal Transduct Res; 2022 Apr; 42(2):133-140. PubMed ID: 33356743
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The predictive power of CD3
    Spanier G; Ugele I; Nieberle F; Symeou L; Schmidhofer S; Brand A; Meier J; Spoerl S; Krupar R; Rümmele P; Siska P; Renner K; Peter K; Gerken M; Beckhove P; Reichert TE; Kreutz M; Singer K
    Cancer Lett; 2021 Feb; 499():209-219. PubMed ID: 33276040
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
    Zhang L; Gao Y; Zhang X; Guo M; Yang J; Cui H; Kong P; Niu X; Bi Y; Xu J; Yan T; Ma Y; Yang J; Qian Y; Wang F; Li H; Liu F; Cheng X; Cui Y
    Theranostics; 2020; 10(24):11339-11358. PubMed ID: 33042286
    [No Abstract]    [Full Text] [Related]  

  • 16. Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics.
    Krämer M; Plum PS; Velazquez Camacho O; Folz-Donahue K; Thelen M; Garcia-Marquez I; Wölwer C; Büsker S; Wittig J; Franitza M; Altmüller J; Löser H; Schlößer H; Büttner R; Schröder W; Bruns CJ; Alakus H; Quaas A; Chon SH; Hillmer AM
    Mol Oncol; 2020 Jun; 14(6):1170-1184. PubMed ID: 32255255
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
    Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
    J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cutaneous spindled follicle center cell lymphoma with abundant mucin: A diagnostic pitfall.
    Li L; Majerowski J; Sokumbi O
    J Cutan Pathol; 2020 Apr; 47(4):394-397. PubMed ID: 31693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.
    Weber F; Junger H; Werner JM; Velez Char N; Rejas C; Schlitt HJ; Hornung M
    Cancer Med; 2019 Nov; 8(16):7065-7073. PubMed ID: 31560833
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increase of cd45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable prognosis for Patients With Barrett's cancer.
    Kemper M; Strohm T; Grupp K; Ghadban T; Bogoevski D; Bachmann K; Bockhorn M; Sauter G; Izbicki JR; Reeh M
    Anticancer Res; 2019 Mar; 39(3):1191-1196. PubMed ID: 30842149
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.